Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Braess

Showing results (51-60 of 84) with videos related to

Pageof 9
Sort By:
Plos One|January 3, 2018
Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk PredictionMichele Pohlen, Nils H Thoennissen, Jan Braess, et al.
Plos One|August 31, 2016
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk PredictionMichele Pohlen, Nils H Thoennissen, Jan Braess, et al.
Genes, Chromosomes & Cancer|April 11, 2012
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3Daniel Nowak, Marion Klaumuenzer, Benjamin Hanfstein, et al.
Hemasphere|July 25, 2025
Clonal hematopoiesis in AML long-term survivors: Risk factors and clinical consequencesSimon M Krauß, Eva Telzerow, Daniel Richter, et al.
Blood Advances|September 17, 2021
A clinically applicable gene expression-based score predicts resistance to induction treatment in acute myeloid leukemiaChristian Moser, Vindi Jurinovic, Sabine Sagebiel-Kohler, et al.
Leukemia|April 2, 2020
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemiaTobias Herold, Maja Rothenberg-Thurley, Victoria V Grunwald, et al.
Scientific Reports|August 15, 2019
Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid LeukaemiaAarif M N Batcha, Stefanos A Bamopoulos, Paul Kerbs, et al.
Annals of Hematology|October 24, 2012
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative GroupEva Lengfelder, Benjamin Hanfstein, Claudia Haferlach, et al.
Blood|January 10, 2009
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCGJan Braess, Karsten Spiekermann, Peter Staib, et al.
Oncotarget|July 27, 2018
Clonal heterogeneity of <i>FLT3</i>-ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemiaKatrin Schranz, Max Hubmann, Egor Harin, et al.
Pageof 9

Showing results (51-60 of 84) with videos related to

Sort By:
Pageof 9
Plos One|January 3, 2018
Correction: Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk PredictionMichele Pohlen, Nils H Thoennissen, Jan Braess, et al.
Plos One|August 31, 2016
Patients with Acute Myeloid Leukemia Admitted to Intensive Care Units: Outcome Analysis and Risk PredictionMichele Pohlen, Nils H Thoennissen, Jan Braess, et al.
Genes, Chromosomes & Cancer|April 11, 2012
SNP array analysis of acute promyelocytic leukemia may be of prognostic relevance and identifies a potential high risk group with recurrent deletions on chromosomal subband 1q31.3Daniel Nowak, Marion Klaumuenzer, Benjamin Hanfstein, et al.
Hemasphere|July 25, 2025
Clonal hematopoiesis in AML long-term survivors: Risk factors and clinical consequencesSimon M Krauß, Eva Telzerow, Daniel Richter, et al.
Blood Advances|September 17, 2021
A clinically applicable gene expression-based score predicts resistance to induction treatment in acute myeloid leukemiaChristian Moser, Vindi Jurinovic, Sabine Sagebiel-Kohler, et al.
Leukemia|April 2, 2020
Validation and refinement of the revised 2017 European LeukemiaNet genetic risk stratification of acute myeloid leukemiaTobias Herold, Maja Rothenberg-Thurley, Victoria V Grunwald, et al.
Scientific Reports|August 15, 2019
Allelic Imbalance of Recurrently Mutated Genes in Acute Myeloid LeukaemiaAarif M N Batcha, Stefanos A Bamopoulos, Paul Kerbs, et al.
Annals of Hematology|October 24, 2012
Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative GroupEva Lengfelder, Benjamin Hanfstein, Claudia Haferlach, et al.
Blood|January 10, 2009
Dose-dense induction with sequential high-dose cytarabine and mitoxantone (S-HAM) and pegfilgrastim results in a high efficacy and a short duration of critical neutropenia in de novo acute myeloid leukemia: a pilot study of the AMLCGJan Braess, Karsten Spiekermann, Peter Staib, et al.
Oncotarget|July 27, 2018
Clonal heterogeneity of <i>FLT3</i>-ITD detected by high-throughput amplicon sequencing correlates with adverse prognosis in acute myeloid leukemiaKatrin Schranz, Max Hubmann, Egor Harin, et al.
Pageof 9